0000000000362482

AUTHOR

Dainius Jančiauskas

showing 8 related works from this author

Lack of Association Between Rs2067474 Polymorphism in the Histamine Receptor H2 Gene and Gastric Cancer In Latvian Population

2018

Abstract Histamine has an important role in the process of the gastric mucosa inflammation acting via histamine receptor H2 (encoded by the gene HRH2). Single nucleotide polymorphism of the enhancer element of HRH2 gene promoter rs2067474 (1018G>A)may be associated with changes of expression of the receptor. We attempted to clarify the association of this polymorphism with gastric cancer and/or atrophic gastritis in the Latvian (Caucasian) population. The study group consisted of 121 gastric cancer patients and 650 patients with no evidence of gastric neoplasia on upper gastrointestinal endoscopy. Genotyping for rs2067474 was performed with the TaqMan probe-based system using a commercia…

medicine.medical_specialtyAtrophic gastritisSciencePopulationSingle-nucleotide polymorphismhistamine h2 receptorGastroenterologychemistry.chemical_compoundHistamine receptorInternal medicineGenotypeGastric mucosagenetic polymorphismMedicineeducationGenotypingeducation.field_of_studyMultidisciplinarybusiness.industrygastric cancerQmedicine.diseasemedicine.anatomical_structurechemistrychronic gastritisbusinessHistamineProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

Ikivėžinių skrandžio gleivinės pokyčių paplitimas Helicobacter pylori sukelto lėtinio gastrito metu tarp Rytų Europos (Lietuvos, Latvijos) ir Azijos …

2007

The aim of the study was to compare the prevalence and severity of precancerous condition – gastric atrophy and intestinal metaplasia (IM) between Eastern European (Lithuania and Latvia) and Asian (Taiwan) countries in population older than 55 years. Methods. Patients aged 55 years and older, referred for upper endoscopy due to dyspeptic symptoms, were included in the study. Gastric biopsies were histological investigated according modified Sydney classification. Helicobacter pylori (H. pylori) was detected if any two of three methods (urease test, histology, and serology) were positive. Results. Overall 322 patients included: 52 from Taiwan (TW), 171 from Latvia (LV) and 99 from Lithuania …

Gastritis AtrophicMalemedicine.medical_specialty616.3 [udc]Helicobacter pylori ; Gastritis atrophic ; Intestinal diseases ; Metaplasia ; Precancerous conditionsBiopsyPopulationTaiwanRapid urease testintestinal metaplasiaGastroenterologyHelicobacter InfectionsAtrophyStomach NeoplasmsMetaplasiaInternal medicineGastroscopyPrevalenceHumansMedicineeducation616.33/.34 [udc]AgedMetaplasiaeducation.field_of_studyHelicobacter pyloribiologybusiness.industryStomachgastritisIntestinal metaplasia<em>Helicobacter pylori</em>; gastritis; atrophy; intestinal metaplasiaLithuaniaGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseasebiology.organism_classificationLatviaEastern europeanFemaleAtrophymedicine.symptomGastritisbusinessPrecancerous Conditions<em>Helicobacter pylori</em>
researchProduct

Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy.

2013

Background Either atrophy or intestinal metaplasia of the gastric mucosa are considered premalignant lesions. The new operative link for gastritis assessment staging system is based on the detection of atrophy, and the operative link for assessment of intestinal metaplasia staging system is based on the detection of intestinal metaplasia. Good interobserver agreement is necessary for identification of any premalignant condition. Aims The aim of this study was to compare the agreement between findings of gastric atrophy and intestinal metaplasia by expert and general pathologists and to analyze the possible reasons behind any possible disagreement. Methods Patients with dyspeptic symptoms, a…

Malemedicine.medical_specialtyBiopsyGastroenterologySeverity of Illness IndexAtrophyStomach NeoplasmsInternal medicineMetaplasiaBiopsymedicineGastric mucosaHumansAntrumAgedObserver VariationMetaplasiaHepatologybiologymedicine.diagnostic_testbusiness.industryGastroenterologyIntestinal metaplasiaHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureGastric MucosaFemaleClinical Competencemedicine.symptomGastritisAtrophybusinessPrecancerous ConditionsEuropean journal of gastroenterologyhepatology
researchProduct

Sa1459 FICE Endoscopy Diagnostic Accuracy by Applying OLGA and OLGIM Systems

2015

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryGastroenterologyDiagnostic accuracyImage enhancementmedicine.diseaseEndoscopyMetaplasiaBiopsymedicineAdenocarcinomaRadiology Nuclear Medicine and imagingRadiologymedicine.symptombusinessGastrointestinal Endoscopy
researchProduct

T1078 The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology

2008

Background Atrophy of the stomach mucosa is considered to be premalignant lesion for gastric cancer development; easy identification of this condition from a blood-sample would allow identifying the group of individuals at increased risk for cancer development.

medicine.medical_specialtyPathologyHepatologybiologybusiness.industryAtrophic gastritisdigestive oral and skin physiologyGastroenterologymedicine.diseaseGastroenterologyIncreased riskAtrophyPepsinInternal medicinemedicinebiology.proteinBiomarker (medicine)HistopathologyCancer developmentbusinessGastric mucosal atrophyGastroenterology
researchProduct

Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage

2011

Introduction The Operative Link for Gastritis Assessment (OLGA) staging system has been proposed as a histopathological reporting system of gastric atrophy. Noninvasive methods for indirect evaluation of gastric mucosal atrophy by biomarkers are also being introduced. Objectives To analyze gastric mucosal atrophy by biomarkers, pepsinogen I (PgI), pepsinogen II (PgII), PgI/PgII ratio, fasting gastrin-17 (G-17), stimulated gastrin-17 (sG-17), in relation to OLGA gastritis stage. Patients and methods Gastric biopsies were taken from 269 prospective patients referred for upper endoscopy because of dyspeptic problems and evaluated by two expert pathologists (D.J. and P.S.). Atrophy was assessed…

AdultGastritis AtrophicMalemedicine.medical_specialtyStage iiPlasma biomarkersGastroenterologyHelicobacter InfectionsAtrophyPepsinogen AInternal medicineGastrinsPepsinogen CHumansMedicineProspective StudiesStage (cooking)Prospective cohort studyAgedAged 80 and overHelicobacter pyloriHepatologybusiness.industryGeneral surgeryGastroenterologyMiddle Agedmedicine.diseaseFemaleGastritismedicine.symptombusinessGastric mucosal atrophyReporting systemBiomarkersEuropean Journal of Gastroenterology &amp; Hepatology
researchProduct

Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.

2017

Background Circulating levels of pepsinogens have been used in high gastric cancer-risk Asian and European populations to triage endoscopic evaluation for more severe pathology. There are different analytic methods with uncertain correlations. We therefore compared diagnostic performance of three commonly used pepsinogen assays to detect histologically confirmed gastric atrophy. Methods We tested plasma samples from adult patients with (n=50) and without (n=755) moderate or severe gastric corpus atrophy, as determined histologically by consensus of three expert pathologists. A single laboratory measured pepsinogens I (PgI) and II (PgII) using commercially available assays: two ELISA assays …

AdultMalePathologymedicine.medical_specialtyAdolescentStomach DiseasesEnzyme-Linked Immunosorbent AssayGastroenterologyArticle03 medical and health sciencesYoung Adult0302 clinical medicineAtrophyPepsinInternal medicineMedicineHumansAgedAged 80 and overAdult patientsPlasma samplesReceiver operating characteristicbiologyPepsinogensbusiness.industryDiagnostic Tests RoutineHistocytochemistryGastric AtrophyStomachGastroenterologyGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesInfectious Diseasesmedicine.anatomical_structureROC CurveGastric Mucosa030220 oncology & carcinogenesisbiology.protein030211 gastroenterology & hepatologyTest performanceFemaleAtrophybusinessLatex Fixation TestsHelicobacter
researchProduct

Value of gastrin-17 in detecting antral atrophy.

2011

Decreased plasma gastrin-17 (G-17), particularly after protein stimulation, is indicative of atrophy in the antral stomach mucosa. Available data on the value of this biomarker is inconclusive. Our study was aimed to evaluate the performance of the G-17 test in Caucasian and Asian patients for antral atrophy evaluation either in fasting state or after protein stimulation.241 dyspeptic patients aged 55 and above from Latvia (125), Lithuania (76) and Taiwan (40) were enrolled. G-17 levels were detected in plasma samples obtained either during fasting or after a protein-rich test meal. Levels1 pmol/L at fast and5 pmol/L after stimulation were considered indicative of atrophy.The sensitivity of…

Gastritis AtrophicMalemedicine.medical_specialtyAtrophic gastritisStimulationGastroenterologySensitivity and SpecificityAtrophyPredictive Value of TestsInternal medicineGastrinsmedicineBiomarkers TumorHumansAntrumAgedAged 80 and overbusiness.industryStomachReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologymedicine.anatomical_structureGastric MucosaPredictive value of testsBiomarker (medicine)FemaleDietary ProteinsGastritismedicine.symptomAtrophybusinessAdvances in medical sciences
researchProduct